News for Johnson & Johnson (JNJ)

Here are the top 5 stocks to buy as the stock market nears all-time highs. Come find strong companies still offering growth potential.

When investors think of artificial intelligence (AI), names like Nvidia (NVDA), Palantir (PLTR), and Alphabet (GOOGL) typically come to mind. But AI’s impact extends well beyond the traditional tech sector. A standout example is Intuitive Surgical (ISRG), the clear global leader in robotic surgery, now making significant strides in integrating AI into healthcare. The company’s latest system, the da Vinci 5, incorporates AI capabilities that could unlock a powerful new and recurring revenue strea

Kenvue Inc., the consumer-health business that was part of Johnson & Johnson, is exploring a sale of some of its skin-care and beauty brands, Reuters reported Thursday, citing people familiar with the matter. The company may sell brands including Clean & Clear, Maui Moisture and Neostrata, according to Reuters, while holding onto bigger brands such as Neutrogena and Aveeno.

After hosting three meets this season, new track league Grand Slam Track makes decision to cancel its final meet in LA.

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why that isn’t a good idea.

Johnson & Johnson (NYSE:JNJ) Goldman Sachs 46th Annual Global Healthcare Conference Call June 11, 2025 3:20 PM ETCompany ParticipantsTom Cavanaugh -...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

JNJ, TMUS, BA, and FRAF show strong momentum as earnings growth, market share, and strategic moves fuel investor confidence.

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, T-Mobile US, and The Boeing Company.

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to dismiss all 17 members of the ACIP has triggered a decline in shares of pharmaceutical companies like Novavax (NVAX), Pfizer (PFE), and Merck (MRK) in after-hours trading. Kennedy’s overhaul, aimed at restoring public trust in vaccine science, raises concerns…

Mark J. Bachleda, PharmD, MBA appointed as independent member of the Board of DirectorsDavid Shook, MD appointed as Chief Medical Officer, Mark Meltz, JD as Gen

You can be subject to CSRD compliance, even if your headquarters is in New York, Houston or Silicon Valley.

(Bloomberg) -- The latest earnings period brought what might be an early warning sign about credit quality for high-grade US companies. Most Read from BloombergNext Stop: Rancho Cucamonga!Where Public Transit Systems Are Bouncing Back Around the WorldICE Moves to DNA-Test Families Targeted for Deportation with New ContractTrump Said He Fired the National Portrait Gallery Director. She’s Still There.US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents WarnCash levels at blue-chip comp

HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (CLDX) today announced that Denice M. Torres has been elected to the company's Boa

Market Analysis by covering: Exxon Mobil Corp, Home Depot Inc, Johnson & Johnson, Crude Oil WTI Futures. Read 's Market Analysis on Investing.com

Addex Therapeutics (ADXN) has revealed promising findings regarding the anti-tussive effectiveness of its innovative gamma-aminobutyric acid sub-type B receptor

Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

AnaptysBio (ANAB) recently conducted a webcast to share encouraging findings from its Phase 2b trial of rosnilimab in treating rheumatoid arthritis. The company